- Lobbying
- Lobbying by American Liver Foundation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dale Dirks Mr | Legislative Consultant |
Priyanka Surio Ms | Legislative Consultant |
Lodriguez Murray Mr | Legislative Consultant |
E. Desmond Taylor Mr | Legislative Consultant |
Dane Christiansen Mr | Legislative Consultant |
Philip Goglas, II Mr | Legislative Consultant |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Centers For Disease Control & Prevention (CDC)
Type of Issue
Registration
Issue(s) they said they’d lobby about: BUD:
LHHS
Defense
Veterans Affairs
HCR:
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC's Division of Viral Hepatitis
Education & Awareness of liver diseases, liver cancer, hepatitis B & C
Patients Access to Treatments Act.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate